CVS HEALTH Corp
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) Stock Repurchases
The following table presents the total number of shares purchased in the three months ended March 31, 2025, the average price paid per share and the approximate dollar value of shares that still could have been purchased at the end of the applicable fiscal period, pursuant to the share repurchase programs authorized by CVS Health Corporation’s Board of Directors on November 17, 2022 and December 9, 2021. See Note 6 ‘‘Shareholders’ Equity’’ contained in “Notes to Condensed Consolidated Financial Statements (Unaudited)” in Part I, Item 1 of this Quarterly Report on Form 10-Q for additional information.
| Fiscal Period · Total Numberof SharesPurchased · AveragePrice Paid perShare · Total Number of SharesPurchased as Part ofPublicly AnnouncedPlans or Programs · Approximate DollarValue of Shares thatMay Yet BePurchased Under thePlans or Programs | |||||
|---|---|---|---|---|---|
| January 1, 2025 through January 31, 2025 | — | $— | — | $11,500,000,143 | |
| February 1, 2025 through February 28, 2025 | — | $— | — | $11,500,000,143 | |
| March 1, 2025 through March 31, 2025 | — | $— | — | $11,500,000,143 | |
| — | — | ||||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.